Gliclazide 30mg modified-release tablets
BNF presentation 0601021M0AAAMAM within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0601021M0AAAMAM
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
84,055
NHS spend (£)
£440,761.40
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 9,753 |
| February 2025 | 176 |
| December 2024 | 4,213 |
| November 2024 | 10,400 |
| October 2024 | 10,682 |
| September 2024 | 61 |
| August 2024 | 1,399 |
| July 2024 | 11,213 |
| May 2024 | 3,911 |
| July 2021 | 6,224 |
| June 2021 | 4,530 |
| December 2020 | 10,604 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 472 | No data available |
| Unknown pharmacy | 232 | No data available |
| Unknown pharmacy | 222 | No data available |
| Unknown pharmacy | 201 | No data available |
| Unknown pharmacy | 185 | No data available |
| Unknown pharmacy | 183 | No data available |
| Unknown pharmacy | 179 | No data available |
| Unknown pharmacy | 179 | No data available |
| Unknown pharmacy | 162 | No data available |
| Unknown pharmacy | 161 | No data available |